Showing results (3331-3340 of 3,354) with videos related to

Sort By:
Pageof 336
Pharmacoeconomics|January 30, 2015
A review and classification of approaches for dealing with uncertainty in multi-criteria decision analysis for healthcare decisionsHenk Broekhuizen, Catharina G M Groothuis-Oudshoorn, Janine A van Til, et al.
Pharmacoeconomics|April 21, 2010
Direct and indirect costs of non-vertebral fracture patients with osteoporosis in the USCrystal Pike, Howard G Birnbaum, Matt Schiller, et al.
Pharmacoeconomics|February 8, 2000
Real world designs in economic evaluation. Bridging the gap between clinical research and policy-makingR Baltussen, R Leidl, A Ament
Pharmacoeconomics|November 4, 1993
Indirect costs in economic studies: confronting the confusionM A Koopmanschap, F F Rutten
Pharmacoeconomics|December 9, 1993
Economic evaluation of lenograstim (glycosylated rHuG-CSF) in the treatment of inflammatory breast cancer for Germany and ItalyV Mapelli, J M Graf vond der Schulenburg, U Laaser, et al.
Pharmacoeconomics|December 9, 1994
Economic evaluations of type II diabetesB Leese
Pharmacoeconomics|December 9, 1994
Evaluative approaches to type II diabetesA Triomphe
Pharmacoeconomics|November 9, 2023
Systematic Review of the Relative Social Value of Child and Adult HealthTessa Peasgood, Martin Howell, Rakhee Raghunandan, et al.
Pharmacoeconomics|September 14, 2013
Cost-effectiveness of rivaroxaban versus warfarin for stroke prevention in atrial fibrillation in the Belgian healthcare settingJoris Kleintjens, Xiao Li, Steven Simoens, et al.
Pharmacoeconomics|May 29, 2015
Sipuleucel-T for the Treatment of Metastatic Hormone-Relapsed Prostate Cancer: A NICE Single Technology Appraisal; An Evidence Review Group PerspectiveEmma L Simpson, Sarah Davis, Praveen Thokala, et al.
Pageof 336